An interventional study of Cognitive Stimulation Therapy and Motor Stimulation Treatment in Dementia, sponsored by Istituto Superiore di Sanità. Recruiting at 1 site in Italy. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-06-04.
Sponsored by Istituto Superiore di Sanità · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 92 studies in Dementia with a site in Italy — 37 open to participants now, 44 under way, 7 of them phase 3. Dementia · Italy.
Among the 92 studies in Dementia with a site in Italy, this one is the 23rd largest by planned enrollment of the 66 interventional ones that give a count, is one of 9 that started in 2025, is one of 29 with no phase, reaches primary completion later than 20 of the 43 other live ones, and was the 87th registered.
2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.
Browse Dementia studies →37 of the 92 studies in Dementia with a site in Italy are open now. Recruiting first, the newest first:
Giovanna Zamboni · Sites in Italy
Ages 40+
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Sites in Italy, Australia, Austria and 14 more countries
Ages 18+
Exciva GmbH · Sites in Italy, United States, Canada and 6 more countries
Ages 55–90
Fondazione Don Carlo Gnocchi ETS · Sites in Italy
Ages 45+
IRCCS Centro Neurolesi Bonino Pulejo · Sites in Italy
Ages 50–86
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
92 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 18 · Phase 3 25 · Phase 4 1
First in 2001; this study’s year is marked. 9 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 421 is above the median of 90 across 1,761 interventional studies indexed under Dementia.
Median enrollment 280 across the 66 interventional studies, 283 across the 26 observational. Of the 39 that completed or were terminated, 12 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
34 of 92 have an industry lead sponsor. The 10 most frequent:
Istituto Superiore di Sanità is the lead sponsor of 17 studies on the registry; 2 are open to participants now.
Istituto Superiore di Sanità has 2 studies filed under Dementia — fewer than ten, so there is no comparison to draw.
12 of the studies in Dementia with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07404410Giovanna ZamboniRobotic Technologies for APATHy in Dementia: a Randomised Controlled Trial (RAPHAel) | 2026-11-30 |
| NCT07625241Istituto Superiore di SanitàCST+MST Intervention on People Living With Mild-to-moderate Dementia | 2026-12 |
| NCT07287410IRCCS Centro Neurolesi Bonino PulejoDementia and Mild Cognitive Impairment: Assessment of Cognitive Functioning, Functional Autonomy, and Neuropsychiatric Symptoms. | 2026-12-20 |
| NCT05794061Istituto Auxologico ItalianoAdvances in Neuropsychological Diagnostics | 2026-12-31 |
| NCT07928453Neuromed IRCCSCardiovascular And Dementia Risk in diabeTes: the Role of Nox2- Related Oxidative Stress. | 2027-01 |
Add all 12 to your calendar (.ics) → With an account.
Among the 92 studies in Dementia with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Non-pharmacological interventions such as Cognitive Stimulation Therapy (CST) and physical activity are recommended for people living with mild-to-moderate dementia. Emerging evidence suggests that combining cognitive and motor interventions may provide synergistic benefits on cognition, mobility, and functional abilities. This study aims to evaluate the effectiveness of a combined CST and Motor Stimulation Treatment (MST) programme.
This multicenter quasi-experimental study will involve 30 clinical centers across five Italian regions. Participants aged ≥65 years with mild-to-moderate dementia will receive 14 combined CST+MST sessions delivered twice weekly over 7 weeks. Assessments will be conducted at baseline, post-intervention, and after 14 weeks by the end of the interventions. Primary outcomes include proportion of responders on the Mini-Mental State Examination (≥2.32 points) and Timed Up and Go test (≥1 point). Secondary outcomes include cognitive, motor, functional, psychological, and caregiver-related measures.
Ethical approval was obtained from the Italian National Ethics Committee in July 2025 (reference number: 2025_0032251). Written informed consent will be obtained from participants and/or their legal representatives, as well as from caregivers involved in the study. All procedures will comply with the Declaration of Helsinki and national data protection regulations. Study findings will be disseminated through peer-reviewed scientific publications and presentations at national and international conferences.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
People living with mild-to-moderate dementia being able to perform a Timed Up and Go test (TUG) regardless of the time taken, i.e. being able to walk independently or with assistance, but without the need for human help during the test, and having no hearing or visual impairments of a degree that would preclude participation in the interventions.
Behavioral: Cognitive Stimulation Therapy and Motor Stimulation Treatment
The intervention will consist of a total of 14 sessions lasting 2 hours each over 7 weeks (twice a week). The intervention will be delivered in groups of 6-8 patients with similar cognitive abilities and will always be carried out by two operators, a psychologist and a physiotherapist. The space will be large enough to allow patients to walk easily in a circle; however, adjustments may be made (e.g. walking on the spot). Each session will consist of an initial 45-minute CST session followed by an MST session. The short break scheduled in the CST protocol will be postponed until the end of this intervention and before the MST session.
Also known as: CST, MST
Mini Mental State Examination (MMSE)
A screening neuropsychological test assessing cognitive global function. The total score is 30. Higher scores indicate better cognitive performance.
Time frame: The test will be administered at baseline, at week 7 and at week 14
Timed and Up Go Test (TUG)
TUG test is a simple clinical measure of functional mobility and fall risk. It records the time (in seconds) needed to stand up from a chair, walk 3 meters, turn, walk back, and sit down. Scores are interpreted as follows: lower times indicate better mobility, with \<10 seconds generally considered normal, 10-20 seconds indicating mild mobility impairment, and \>20-30 seconds suggesting increased fall risk and functional limitation, depending on clinical context.
Time frame: Baseline, week 7, and week 14
Plan to share: Yes — We will share individual participant data (IPD) including baseline demographic and clinical characteristics, outcome measures collected during and after the intervention (e.g., cognitive, functional, and motor assessments), and relevant safety/adverse event data. All shared IPD will be de-identified to ensure participant confidentiality.
Supporting information: Study protocol, Statistical analysis plan
Time frame: At the end of the study
Access criteria: Immediately after the first publication of the results. IPD wil be shared through scientific publications.
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Dec 2026, 17 months after the start.
Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 17 months is below that.
Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istituto Superiore di Sanità